We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.91B
1-Year Est. Return 44.39%
This Fund
S&P 500
This Quarter Est. Return
+36.84%
1 Year Est. Return
+44.39%
3 Year Est. Return
+110.36%
5 Year Est. Return
+52.4%
10 Year Est. Return
+1,142.23%
AUM
$1.91B
AUM Growth
+$494M
Cap. Flow
+$3.72M
Cap. Flow %
0.19%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
IMDX
Insight Molecular Diagnostics
IMDX
+$3.72M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Staples 40.73%
2 Healthcare 31.49%
3 Industrials 20.32%
4 Miscellaneous 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNST icon
1
Monster Beverage
MNST
$87.7B
$779M 40.73%
16,215,592
– –
STAA icon
2
STAAR Surgical
STAA
$1.14B
$463M 24.18%
16,123,842
– –
AXON
3
Axon Enterprise
AXON
$38.2B
$389M 20.32%
693,504
– –
IWM icon
4
iShares Russell 2000 ETF
IWM
$77.2B
$143M 7.46%
474,920
– –
IMDX
5
Insight Molecular Diagnostics
IMDX
$126M
$74.8M 3.91%
12,684,884
+753,045
+6% +$3.72M
LCTX icon
6
Lineage Cell Therapeutics
LCTX
$266M
$64.9M 3.39%
49,560,992
– –

Similar funds

EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.91B AUM 19.99% 1-Year Est. Return
RMA
Roffman Miller Associates Philadelphia, Pennsylvania $1.91B AUM 28.29% 1-Year Est. Return
LWMT
Legacy Wealth Management (Tennessee) Memphis, Tennessee $1.91B AUM 17.42% 1-Year Est. Return
FIB
First Interstate Bank Billings, Montana $1.92B AUM 19.65% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $1.92B AUM 6.41% 1-Year Est. Return
HPC
Hill Path Capital New York $1.92B AUM 5.67% 1-Year Est. Return
R
Rebalance Palo Alto, California $1.91B AUM 16.23% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

Broadwood Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Broadwood Capital held 6 positions worth $1.91B, up 35% from $1.42B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 0%. Broadwood Capital opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Staples at 41% of assets, down from 41% a quarter earlier, followed by Healthcare and Industrials.

  • Broadwood Capital added most to Insight Molecular Diagnostics in Q2 2026, an estimated $3.72M increase.
  • Broadwood Capital's ten largest holdings make up 100% of its $1.91B portfolio in Q2 2026.
  • Broadwood Capital opened 0 new positions and closed 0 in Q2 2026.
  • Broadwood Capital's portfolio value rose 35% quarter-over-quarter to $1.91B.

Based on Broadwood Capital's 13F filing for Q2 2026, filed 14 Aug 2026.